Express News Service BENGALURU: Bharat Biotech, the developer of the indigenously developed Covid-19 vaccine Covaxin, is said to have submitted its Phase II/III clinical...
Bharat Biotech
All the relevant trial data has been submitted to WHO, and all clarifications by the UN health agency have been responded to Bharat Biotech.
By PTI HYDERABAD: Indian Immunologicals Limited which has supplied two million doses of drug substance to Bharat Biotech to make COVID-19 vaccine Covaxin, is set...
By PTI HYDERABAD: Bharat Biotech on Friday said it has submitted all the data pertaining to its COVID-19 vaccine Covaxin to the World health...
By Express News Service NEW DELHI: The World Health Organisation is set to recognise Covaxin, India’s first home-grown Covid19 vaccine, within a week bringing...
Hyderabad-based Bharat Biotech, the manufacturer of COVID-19 Covaxin, said the efficacy of its vaccine would have been 85 per cent against the original strain...
By PTI ANKLESHWAR: The first commercial batch of Covaxin was released on Sunday from the new plant of Bharat Biotech at Ankleshwar in Gujarat’s...
By PTI NEW DELHI: A single dose of Bharat Biotech’s Covaxin in previously COVID-19-infected individuals elicits a similar antibody response as obtained with two...
Express News Service NEW DELHI: Those who have got one dose of Covaxin after having contracted Covid infection before may have the same level...
By PTI NEW DELHI: The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator’s nod for conducting phase 2 and 3...